Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 16;16(3):e56251.
doi: 10.7759/cureus.56251. eCollection 2024 Mar.

Prevalence and Epidemiological Characteristics of Anogenital Warts Among Recently Diagnosed HIV-Positive Women on Antiretroviral Therapy in Lagos, Nigeria

Affiliations

Prevalence and Epidemiological Characteristics of Anogenital Warts Among Recently Diagnosed HIV-Positive Women on Antiretroviral Therapy in Lagos, Nigeria

Ayodeji K Adefemi et al. Cureus. .

Abstract

Background Anogenital warts (AGWs) are a prevalent condition resulting from human papillomavirus (HPV) infection, which is the most frequently encountered sexually transmitted infection (STI) on a global scale. Women who are HIV-positive experience a disproportionately high burden of AGWs compared to other populations. It is imperative to comprehend the epidemiological factors linked to the disease within this particular at-risk population. Objectives The objective of the study was to ascertain the prevalence of AGWs and its demographic and socio-biological epidemiological features among recently diagnosed HIV-positive women (HPW) in Lagos, Nigeria. Materials and methods The research was a descriptive cross-sectional study conducted among a sample of 420 recently diagnosed HPW. The study was conducted at the HIV clinic of a tertiary health institution located in Lagos, Nigeria. The participants clinically diagnosed with AGWs were classified as the study group, while individuals without AGWs were classified as the comparison group. Interviewer-administered pretested questionnaires were utilized to gather pertinent demographic and socio-biological epidemiological data from the participants involved in the study. The data were analyzed using IBM SPSS Statistics for Windows, Version 23.0 (Released 2015; IBM Corp., Armonk, New York, USA). Results The prevalence of AGWs among recently diagnosed HPW was found to be 8.5% (34/402). These warts were frequently observed on the vulvar labia (35.3%, 12/34), vaginal walls (14.7%, 5/34), and perianal region (14.7%, 5/34). It is worth noting that over a third of cases (35.3%, 12/34) involved multiple areas within the anogenital region. The diagnosis of AGWs was found to have significant associations with occupation (p=0.005), marital status (p<0.001), and educational status (p=0.028). The majority of HPW diagnosed with AGWs were unemployed (32.4%, 11/34), single (47.1%, 16/34), and did not have tertiary education (94.1%, 32/34). The utilization of oral contraceptive pills (OCPs), smoking, low CD4 count, and high viral load were the significant socio-biological factors associated with the diagnosis of AGWs (p<0.001, respectively). Conclusion The study found that the prevalence of AGW among HPW was 8.5% (34/402). Several epidemiological factors, including occupation, marital status, education, CD4 count, viral load, history of OCP use, and smoking, were found to be significantly associated with the diagnosis of AGW. There is a need to conduct more comprehensive studies to thoroughly assess the impact of these epidemiological factors.

Keywords: anogenital warts; anti-retroviral therapy; epidemiology; hiv-positive women; human immunodeficiency virus (hiv); human papillomavirus (hpv); lagos; nigeria; people living with hiv/aids; prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Site distribution of AGWs among recently diagnosed HPW on antiretroviral drugs (n=34).
AGWs: anogenital warts; HPW: HIV-positive women. The data have been represented as frequency (n) and percentage (%).

References

    1. Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination. Tyros G, Mastraftsi S, Gregoriou S, Nicolaidou E. Int J STD AIDS. 2021;32:4–13. - PubMed
    1. Effectiveness of topical and ablative therapies in treatment of anogenital warts: a systematic review and network meta-analysis. Barton S, Wakefield V, O'Mahony C, Edwards S. BMJ Open. 2019;9:0. - PMC - PubMed
    1. Update on the epidemiological features and clinical implications of human papillomavirus infection (HPV) and human immunodeficiency virus (HIV) coinfection. Pérez-González A, Cachay E, Ocampo A, Poveda E. Microorganisms. 2022;10:1047. - PMC - PubMed
    1. Incidence, persistence, clearance, and correlates of genital human papillomavirus infection and anogenital warts in a cohort of men living with human immunodeficiency virus in South Africa. Chikandiwa A, Pisa PT, Muller EE, Tamalet C, Mayaud P, Chersich MF, Delany-Moretlwe S. Sex Transm Dis. 2019;46:347–353. - PMC - PubMed
    1. Ano-genital warts and HIV status- a clinical study. Dhumale SB, Sharma S, Gulbake A. J Clin Diagn Res. 2017;11:0–4. - PMC - PubMed

LinkOut - more resources